{"symbol":"LLY","fiscalQuarter":"Q3-2011","reportDate":"2011-10-20","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q3-2011","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down 0.23%","keyNumbers":[{"metric":"EPS","actual":"$1.13","expected":"N/A","surprise":"-0.44%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a slight miss on EPS, which led to a small decline in the stock price by 0.23%. The lack of revenue data and management commentary means investors have limited insights into the company's performance and future outlook.","metaDescription":"Eli Lilly (LLY) Q3 2011 earnings: EPS missed expectations. Stock down 0.23%. Full breakdown."}}